Serum proteomic profiling in granumomatosis with polyangiitis using two-dimensional gel electrophoresis along with matrix assisted laser desorption ionization time of flight mass spectrometry

International Journal of Rheumatic Diseases

Volumn 17, Issue 8, 2014, Pages 910-919

  Rani, Lekha ^a   Minz, Ranjana W ^a   Arora, Amit ^b   Kannan, Monica ^c   Sharma, Aman ^a   Anand, Shashi ^a   Gupta, Dheeraj ^a   Panda, Naresh K ^a   Sakhuja, Vinay K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

^c UNIVERSITY OF HYDERABAD   (India)

Author keywords

2D PAGE; Biomarker; Disease activity; Mass spectrometry; Proteomics

Indexed keywords

A RAF KINASE; CYCLOPHOSPHAMIDE; CYSTEINE RICH SECRETROY PROTEIN LCCL DOMAIN CONTAINING 2 PRECURSOR; HAPTOGLOBIN; HAPTOGLOBIN 2; IMMUNOGLOBULIN; IMMUNOGLOBULIN 4 CHAIN C REGION PROTEIN; INTERLEUKIN 17; KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY F MEMBER 2; METHOTREXATE; PROLOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 1; PROTEIN; RITUXIMAB; SECRETORY PROTEIN; SERUM ALBUMIN; STEROID; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; STEROID THERAPY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WEGENER GRANULOMATOSIS; BLOOD; MASS SPECTROMETRY; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PROTEIN MICROARRAY;

ADULT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GRANULOMATOSIS WITH POLYANGIITIS; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

EID: 84921984224     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12481     Document Type: Article

References (38)

1. Stone JH (2003) Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 48, 2299-309.
2. Stone JH, Rajapakse VN, Hoffman GS et al. (2005) A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. Arthritis Rheum 52, 902-10.
3. Olle EW, Deogracias MP, Messamore JE et al. (2007) Screening of serum samples from Wegener's granulomatosis patients using antibody microarrays. Proteomics Clin Appl 1, 1212-20.
4. Monach PA, Warner RL, Tomasson G et al. (2012) Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis 72, 1342-50.
5. Stone JH, Hoffman GS, Merkel PA et al. (2001) A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44, 912-20.
6. Chen YY, Lin SY, Yeh YY et al. (2005) A modified protein precipitation procedure for efficient removal of albumin from serum. Electrophoresis 26, 2117-27.
7. Stults JT (1995) Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). Curr Opin Struct Biol 5, 691-8.
8. Buehler PW, Abraham B, Vallelian F et al. (2009) Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113, 2578-86.
9. Oliveira LH, Franca MC Jr, Nucci A et al. (2008) Haptoglobin study in myasthenia gravis. Arq Neuropsiquiatr 66, 229-33.
10. Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E et al. (2010) Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Adv Med Sci 55, 80-5.
11. Cid MC, Grant DS, Hoffman GS et al. (1993) Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91, 977-85.
12. Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42, 1589-600.
13. Van Vlierberghe H, Langlois M, Delanghe J (2004) Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 345, 35-42.
14. Marquez L, Shen C, Cleynen I et al. (2012) Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Gut 61, 528-34.
15. Papp M, Foldi I, Nemes E et al. (2008) Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. Clin Chem 54, 697-704.
16. Costacou T, Ferrell RE, Orchard TJ (2008) Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes 57, 1702-6.
17. Spreu J, Kuttruff S, Stejfova V et al. (2010) Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes. Proc Natl Acad Sci USA 107, 5100-5.
18. Gressner O, Meier U, Hillebrandt S et al. (2007) Gc-globulin concentrations and C5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor C5. Clin Biochem 40, 771-5.
19. Shah AB, DiMartino SJ, Trujillo G et al. (2006) Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1, 25(OH)2 vitamin D3. Mol Immunol 43, 1109-15.
20. Yan X, Zhao Y, Pan J et al. (2012) Vitamin D-binding protein (group-specific component) has decreased expression in rheumatoid arthritis. Clin Exp Rheumatol 30, 525-33.
21. Blanton D, Han Z, Bierschenk L et al. (2011) Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 60, 2566-70.
22. Yang M, Qin Z, Zhu Y et al. (2013) Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression. Mol Neurobiol 47, 946-56.
23. Eriksson C, Rantapaa-Dahlqvist S, Sundqvist KG (2010) T-cell expression of CD91 - a marker of unresponsiveness to anti-TNF therapy in rheumatoid arthritis. APMIS 118, 837-45.
24. Gorovoy M, Gaultier A, Campana WM et al. (2010) Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. J Leukoc Biol 88, 769-78.
25. Peters T (1996) All About Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, San Diego.
26. Croonenberghs J, Wauters A, Devreese K et al. (2002) Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32, 1457-63.
27. Thomas L (1998). Clinical Laboratory Diagnostics: Use and Assessment of Clinical Laboratory Results. TH-Books, Frankfurt, Germany.
28. Gibbs GM, Roelants K, O'Bryan MK (2008) The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins-roles in reproduction, cancer, and immune defense. Endocr Rev 29, 865-97.
29. Roskoski R Jr (2010) RAF protein-serine/threonine kinases: structure and regulation. Biochem Biophys Res Commun 399, 313-7.
30. Boumpas DT, Tsokos GC, Mann DL et al. (1986) Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 29, 755-60.
31. Auger I, Balandraud N, Rak J et al. (2009) New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis 68, 591-4.
32. Cunnane G, Whitehead AS (1999) Amyloid precursors and amyloidosis in rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol 13, 615-28.
33. Cunnane G, Grehan S, Geoghegan S et al. (2000) Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol 27, 58-63.
34. Nogueira E, Hamour S, Sawant D et al. (2010) Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 25, 2209-17.
35. Wong CK, Lit LC, Tam LS et al. (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127, 385-93.
36. van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5, 549-53.
37. Mouawad L, Perahia D, Robert CH et al. (2002) New insights into the allosteric mechanism of human hemoglobin from molecular dynamics simulations. Biophys J 82, 3224-45.
38. Paoli M, Liddington R, Tame J et al. (1996) Crystal structure of T state haemoglobin with oxygen bound at all four haems. J Mol Biol 256, 775-92.